Legal Statement.

GALDERMA LABORATORIES, L.P.
IMPORTANT LEGAL INFORMATION

Galderma Laboratories, L.P.
P.O. Box 331329
Fort Worth, Texas 76163-1329.

All use of the Differin Web site is subject to the terms and conditions set forth below. Any use of such Web pages constitutes the user's agreement to abide by the following terms and conditions.

Galderma Differin Web pages are designed for educational purposes only. This information is not intended to substitute for informed medical advice. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified health care provider. Galderma Laboratories, L.P. does not endorse or attest to the validity or accuracy of any treatments, medications, or non-Galderma products discussed herein. Before acting on any information contained on the Web pages, you agree that you will consult your health care provider to determine whether the information you are relying on is appropriate for your medical conditions.

All information provided by Galderma is owned by or licensed to Galderma. Galderma and its licensors retain all proprietary rights to the information contained on the pages. Except for making one hard copy print of the information or downloading the material for a one-time use, information on the pages may not be reproduced, transmitted, distributed, or displayed, without the express consent of Galderma.

THIS WEB SITE IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. THIS WEB SITE COULD INCLUDE TECHNICAL INACCURACIES OR TYPOGRAPHICAL ERRORS. CHANGES ARE PERIODICALLY ADDED TO THE INFORMATION HEREIN; THESE CHANGES WILL BE INCORPORATED IN NEW EDITIONS OF THE WEB SITE. GALDERMA MAY MAKE IMPROVEMENTS AND/OR CHANGES IN THE PRODUCT(S) AND/OR THE PROGRAM(S) DESCRIBED IN THIS WEB SITE AT ANY TIME.

For further intellectual property information regarding the Galderma Differin Web site, please contact webmaster@galderma.com.

Differin^® Lotion 0.1% and Differin^® Gel 0.3% are indicated for the topical treatment of acne vulgaris in patients 12 years and older. Cutaneous irritation (erythema, scaling, dryness and/or stinging/burning) has been reported in clinical studies of these products. The majority of cases were mild to moderate in severity, occurred early in treatment and decreased thereafter. Other side effects that may occur from using Differin Lotion 0.1% and Differin Gel 0.3% include dry skin, skin discomfort, pruritus, desquamation and sunburn.

Concomitant use of potentially irritating products or overexposure to sunlight or sunlamps, extreme wind or cold, may increase the potential for irritation. Use of sunscreen and protective clothing over treated areas are recommended when exposure cannot be avoided. Do not use Differin Lotion 0.1% and Differin Gel 0.3% if you are allergic to adapalene or any of the other ingredients in the product. Talk to your doctor to learn more about Differin Lotion 0.1% and Differin Gel 0.3%.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

*Insured patients could pay no more than $35 for their Differin^® (adapalene) Gel, 0.3% or Differin^® (adapalene) Lotion Pump, 0.1% prescription (for one tube or pump, after primary insurance and the Differin Savings at Work Card and includes a maximum benefit of $210). Restrictions may apply.

Home

Legal

Privacy

Prescribing Information

©2012 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.